In-Process Checks During Tablet Compression: GMP Requirements and Practical Challenges

Introduction

Tablet compression is one of the most critical stages in pharmaceutical manufacturing. Even when granulation and blending are performed correctly, poor control during compression can lead to major quality defects such as weight variation, hardness issues, capping, lamination, and dissolution failure.

That is why in-process checks (IPCs) are mandatory under Good Manufacturing Practices (GMP). These checks ensure that tablets being produced meet quality standards while the batch is running, not just at the end.

From real production experience, many batch rejections happen not because the formula was wrong, but because in-process checks were skipped, delayed, or not properly recorded. IPCs are the early warning system of tablet manufacturing.

---

What Are In-Process Checks?

In-process checks are tests performed during manufacturing to monitor and control the process. During tablet compression, IPCs help ensure that every tablet meets the required specifications for:

• Weight
• Hardness
• Thickness
• Friability
• Disintegration

These checks are performed at defined intervals and recorded in the Batch Manufacturing Record (BMR).

---

Why In-Process Checks Are Important

1. Ensure Uniformity of Dosage

Weight variation directly affects the amount of active ingredient in each tablet.

2. Detect Problems Early

Machine issues like worn punches or improper feed can be detected before large quantities are rejected.

3. Maintain GMP Compliance

Regulatory inspectors carefully review IPC records to confirm process control.

4. Reduce Batch Rejection

Early correction prevents major losses later.

In real manufacturing environments, operators sometimes focus on speed, but GMP requires that quality checks are never sacrificed for production output.

---

Major In-Process Checks During Tablet Compression

1. Tablet Weight Variation

This is the most frequent IPC.

Purpose:
Ensure each tablet contains the correct dose.

Procedure:

• Collect tablets at regular intervals (e.g., every 15–30 minutes)
• Weigh individually or as per SOP
• Compare with target weight limits

Experience Insight:
Weight variation often occurs due to uneven granule flow. I have seen cases where the hopper level dropped too low, causing underweight tablets until the issue was noticed.

---

2. Tablet Hardness Test

Hardness measures the force required to break a tablet.

Purpose:
Ensure tablets are strong enough to handle packing and transport, but still dissolve properly.

Problems Seen in Practice:

• Too hard → slow dissolution
• Too soft → breakage during coating or packing

Hardness can change due to compression force adjustments or variation in granule moisture.

---

3. Tablet Thickness

Thickness must remain consistent for proper packaging, especially blister packing.

Why It Matters:

• Affects packing machine performance
• Indicates compression force changes

In real production, sudden thickness variation often signals mechanical problems with punches or dies.

---

4. Friability Test

Friability measures tablet resistance to abrasion.

Purpose:
Ensure tablets do not crumble during handling.

Common Cause of Failure:
Low binder content or insufficient compression force.

I have seen friability failures when granules were overdried, reducing their binding properties.

---

5. Disintegration Time

This test checks how quickly a tablet breaks down in a liquid medium.

Why Important:

• Ensures medicine is released properly in the body

Excessive lubricant mixing or very high hardness can delay disintegration — a frequent real-world issue when blending times are not controlled.

---

Frequency of In-Process Checks

The frequency is defined in the BMR or SOP, but typically includes:

• At the start of compression
• At regular intervals (every 15–60 minutes)
• After machine adjustments
• At the end of the batch

Skipping checks during busy shifts is a common GMP observation during audits.

---

Actions When Results Are Out of Limit (OOL)

If any IPC result is outside limits:

1. Stop compression immediately
2. Inform Production Supervisor and QA
3. Segregate affected tablets
4. Investigate the root cause
5. Make necessary machine adjustments
6. Document everything

Continuing compression without investigation is a serious GMP violation.

---

Documentation of In-Process Checks

All IPC results must be recorded clearly in the BMR:

• Time of check
• Results
• Operator signature
• Reviewer signature

Corrections must follow Good Documentation Practices (GDP).

From experience, missing IPC entries are treated as if the checks were never done — even if tablets were actually tested.

---

Common Practical Challenges During Tablet Compression

1. Machine Speed Pressure

Operators may feel pressure to increase speed, which can reduce control over weight variation.

2. Punch and Die Wear

Worn tooling can change tablet weight and thickness.

3. Granule Flow Problems

Bridging in the hopper leads to inconsistent fill.

4. Poor Recording Habits

Delays in writing IPC results lead to data integrity concerns.

Real GMP culture means recording results immediately, not at the end of the shift.

---

GMP Expectations from Regulatory Inspectors

Inspectors usually check:

• Whether IPC frequency matches SOP
• Whether any OOL results occurred
• Whether proper action was taken
• Whether the records are complete and signed

Loose control in IPCs often leads to regulatory observations.

---

Conclusion

In-process checks during tablet compression are essential to ensure uniform quality, regulatory compliance, and patient safety. They provide real-time control over the manufacturing process and help detect issues before they become major failures.

From practical pharmaceutical production experience, strong IPC discipline reduces deviations, prevents batch rejection, and builds a strong GMP culture on the shop floor.

Tablet compression is not just about making tablets fast — it is about making every tablet right.